Cargando…
Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932399/ https://www.ncbi.nlm.nih.gov/pubmed/36795304 http://dx.doi.org/10.1007/s40121-023-00770-9 |
| _version_ | 1784889442446606336 |
|---|---|
| author | Sinha, Sanjeev Ajayababu, Anuj Thukral, Himanshu Gupta, Sushil Guha, Subhasish Kamal Basu, Ayan Gupta, Gaurav Thakur, Prashant Lingaiah, Raghavendra Das, Bimal Kumar Singh, Urvashi B. Singh, Ravinder Narang, Rajiv Bhowmik, Dipankar Wig, Naveet Modak, Dolan Champa Bandyopadhyay, Bhaswati Chakrabarty, Banya Kapoor, Aditya Tewari, Satyendra Prasad, Narayan Hashim, Zia Nath, Alok Kumari, Niraj Goswami, Ravinder Pandey, Shivam Pandey, Ravindra Mohan |
| author_facet | Sinha, Sanjeev Ajayababu, Anuj Thukral, Himanshu Gupta, Sushil Guha, Subhasish Kamal Basu, Ayan Gupta, Gaurav Thakur, Prashant Lingaiah, Raghavendra Das, Bimal Kumar Singh, Urvashi B. Singh, Ravinder Narang, Rajiv Bhowmik, Dipankar Wig, Naveet Modak, Dolan Champa Bandyopadhyay, Bhaswati Chakrabarty, Banya Kapoor, Aditya Tewari, Satyendra Prasad, Narayan Hashim, Zia Nath, Alok Kumari, Niraj Goswami, Ravinder Pandey, Shivam Pandey, Ravindra Mohan |
| author_sort | Sinha, Sanjeev |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9932399 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99323992023-02-16 Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial Sinha, Sanjeev Ajayababu, Anuj Thukral, Himanshu Gupta, Sushil Guha, Subhasish Kamal Basu, Ayan Gupta, Gaurav Thakur, Prashant Lingaiah, Raghavendra Das, Bimal Kumar Singh, Urvashi B. Singh, Ravinder Narang, Rajiv Bhowmik, Dipankar Wig, Naveet Modak, Dolan Champa Bandyopadhyay, Bhaswati Chakrabarty, Banya Kapoor, Aditya Tewari, Satyendra Prasad, Narayan Hashim, Zia Nath, Alok Kumari, Niraj Goswami, Ravinder Pandey, Shivam Pandey, Ravindra Mohan Infect Dis Ther Correction Springer Healthcare 2023-02-16 2023-03 /pmc/articles/PMC9932399/ /pubmed/36795304 http://dx.doi.org/10.1007/s40121-023-00770-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Sinha, Sanjeev Ajayababu, Anuj Thukral, Himanshu Gupta, Sushil Guha, Subhasish Kamal Basu, Ayan Gupta, Gaurav Thakur, Prashant Lingaiah, Raghavendra Das, Bimal Kumar Singh, Urvashi B. Singh, Ravinder Narang, Rajiv Bhowmik, Dipankar Wig, Naveet Modak, Dolan Champa Bandyopadhyay, Bhaswati Chakrabarty, Banya Kapoor, Aditya Tewari, Satyendra Prasad, Narayan Hashim, Zia Nath, Alok Kumari, Niraj Goswami, Ravinder Pandey, Shivam Pandey, Ravindra Mohan Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
| title | Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
| title_full | Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
| title_fullStr | Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
| title_full_unstemmed | Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
| title_short | Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
| title_sort | correction to: efficacy of bacillus calmette–guérin (bcg) vaccination in reducing the incidence and severity of covid-19 in high-risk population (bric): a phase iii, multi-centre, quadruple-blind randomised control trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932399/ https://www.ncbi.nlm.nih.gov/pubmed/36795304 http://dx.doi.org/10.1007/s40121-023-00770-9 |
| work_keys_str_mv | AT sinhasanjeev correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT ajayababuanuj correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT thukralhimanshu correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT guptasushil correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT guhasubhasishkamal correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT basuayan correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT guptagaurav correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT thakurprashant correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT lingaiahraghavendra correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT dasbimalkumar correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT singhurvashib correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT singhravinder correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT narangrajiv correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT bhowmikdipankar correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT wignaveet correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT modakdolanchampa correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT bandyopadhyaybhaswati correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT chakrabartybanya correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT kapooraditya correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT tewarisatyendra correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT prasadnarayan correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT hashimzia correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT nathalok correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT kumariniraj correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT goswamiravinder correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT pandeyshivam correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial AT pandeyravindramohan correctiontoefficacyofbacilluscalmetteguerinbcgvaccinationinreducingtheincidenceandseverityofcovid19inhighriskpopulationbricaphaseiiimulticentrequadrupleblindrandomisedcontroltrial |